Veru (VERU) Shares Outstanding (Diluted) (2010 - 2026)
Veru's Shares Outstanding (Diluted) was 14.64 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), unchanged from 14.64 million a year earlier and unchanged from the prior quarter.
Veru (VERU) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends
From fiscal Q4 2010 onward, Veru has reported Shares Outstanding (Diluted) for 64 quarters.
- Shares Outstanding (Diluted) shows a five-year compound annual growth rate of 17.0% (FY2020 to FY2025).
- In earlier fiscal years, Shares Outstanding (Diluted) was 14.64 million in FY2024 (+72.3%), 8.5 million in FY2023 (+6.1%), 8.01 million in FY2022 (-4.4%) and 8.38 million in FY2021 (+25.5%).
- Compared with a year earlier, Shares Outstanding (Diluted) was higher in two of the last eight quarters, with growth averaging 14.7%.
- The best year-over-year quarter for Shares Outstanding (Diluted) over five years was fiscal Q2 2024 (growth of 81.1%); the worst was fiscal Q4 2022 (a decline of 4.4%).
- Per Business Quant data, VERU's Shares Outstanding (Diluted) in the three fiscal quarters before Q3 2026 was 14.64 million (Q2 2026), 14.64 million (Q1 2026) and 14.64 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Veru | 58.55 Mn | -51.72 Mn | - | 14.64 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.64 Mn |
| Mar 31, 2026 | 14.64 Mn |
| Dec 31, 2025 | 14.64 Mn |
| Sep 30, 2025 | 14.64 Mn |
| Jun 30, 2025 | 14.64 Mn |
| Mar 31, 2025 | 14.64 Mn |
| Dec 31, 2024 | 14.64 Mn |
| Sep 30, 2024 | 14.64 Mn |
| Jun 30, 2024 | 14.64 Mn |
| Mar 31, 2024 | 14.64 Mn |
| Dec 31, 2023 | 10.06 Mn |
| Sep 30, 2023 | 8.50 Mn |
| Jun 30, 2023 | 8.83 Mn |
| Mar 31, 2023 | 8.08 Mn |
| Dec 31, 2022 | 8.06 Mn |
| Sep 30, 2022 | 8.01 Mn |
| Jun 30, 2022 | 8.01 Mn |
| Mar 31, 2022 | 8.01 Mn |
| Dec 31, 2021 | 8.00 Mn |
| Sep 30, 2021 | 8.38 Mn |
Veru Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=VERU&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "VERU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=VERU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();